The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global RNAi Therapy Market 2024 by Company, Regions, Type and Application, Forecast to 2029
Synopsis
The global RNAi Therapy market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
This report is a detailed and comprehensive analysis for global RNAi Therapy market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global RNAi Therapy market size and forecasts, in consumption value ($ Million), 2018-2029
Global RNAi Therapy market size and forecasts by region and country, in consumption value ($ Million), 2018-2029
Global RNAi Therapy market size and forecasts, by Type and by Application, in consumption value ($ Million), 2018-2029
Global RNAi Therapy market shares of main players, in revenue ($ Million), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for RNAi Therapy
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global RNAi Therapy market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Alnylam, Sarepta Therapeutics, Alnylam Pharmaceuticals, Moderna and Sanofi, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market segmentation
RNAi Therapy market is split by Type and by Application. For the period 2018-2029, the growth among segments provide accurate calculations and forecasts for consumption value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Small Molecule Interfering Ribonucleic Acid (SiRNA)
Microrna (MiRNA)
Market segment by Application
Oncology
Cardiology
Others
Market segment by players, this report covers
Alnylam
Sarepta Therapeutics
Alnylam Pharmaceuticals
Moderna
Sanofi
Arcturus Therapeutics
Silence
Sirnaomics
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Argentina and Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe RNAi Therapy product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of RNAi Therapy, with revenue, gross margin and global market share of RNAi Therapy from 2018 to 2023.
Chapter 3, the RNAi Therapy competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and RNAi Therapy market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War
Chapter 12, the key raw materials and key suppliers, and industry chain of RNAi Therapy.
Chapter 13, to describe RNAi Therapy research findings and conclusion.
The global RNAi Therapy market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
This report is a detailed and comprehensive analysis for global RNAi Therapy market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global RNAi Therapy market size and forecasts, in consumption value ($ Million), 2018-2029
Global RNAi Therapy market size and forecasts by region and country, in consumption value ($ Million), 2018-2029
Global RNAi Therapy market size and forecasts, by Type and by Application, in consumption value ($ Million), 2018-2029
Global RNAi Therapy market shares of main players, in revenue ($ Million), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for RNAi Therapy
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global RNAi Therapy market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Alnylam, Sarepta Therapeutics, Alnylam Pharmaceuticals, Moderna and Sanofi, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market segmentation
RNAi Therapy market is split by Type and by Application. For the period 2018-2029, the growth among segments provide accurate calculations and forecasts for consumption value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Small Molecule Interfering Ribonucleic Acid (SiRNA)
Microrna (MiRNA)
Market segment by Application
Oncology
Cardiology
Others
Market segment by players, this report covers
Alnylam
Sarepta Therapeutics
Alnylam Pharmaceuticals
Moderna
Sanofi
Arcturus Therapeutics
Silence
Sirnaomics
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Argentina and Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe RNAi Therapy product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of RNAi Therapy, with revenue, gross margin and global market share of RNAi Therapy from 2018 to 2023.
Chapter 3, the RNAi Therapy competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and RNAi Therapy market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War
Chapter 12, the key raw materials and key suppliers, and industry chain of RNAi Therapy.
Chapter 13, to describe RNAi Therapy research findings and conclusion.
Index1 Market Overview
1.1 Product Overview and Scope of RNAi Therapy
1.2 Market Estimation Caveats and Base Year
1.3 Classification of RNAi Therapy by Type
1.3.1 Overview: Global RNAi Therapy Market Size by Type: 2018 Versus 2022 Versus 2029
1.3.2 Global RNAi Therapy Consumption Value Market Share by Type in 2022
1.3.3 Small Molecule Interfering Ribonucleic Acid (SiRNA)
1.3.4 Microrna (MiRNA)
1.4 Global RNAi Therapy Market by Application
1.4.1 Overview: Global RNAi Therapy Market Size by Application: 2018 Versus 2022 Versus 2029
1.4.2 Oncology
1.4.3 Cardiology
1.4.4 Others
1.5 Global RNAi Therapy Market Size & Forecast
1.6 Global RNAi Therapy Market Size and Forecast by Region
1.6.1 Global RNAi Therapy Market Size by Region: 2018 VS 2022 VS 2029
1.6.2 Global RNAi Therapy Market Size by Region, (2018-2029)
1.6.3 North America RNAi Therapy Market Size and Prospect (2018-2029)
1.6.4 Europe RNAi Therapy Market Size and Prospect (2018-2029)
1.6.5 Asia-Pacific RNAi Therapy Market Size and Prospect (2018-2029)
1.6.6 South America RNAi Therapy Market Size and Prospect (2018-2029)
1.6.7 Middle East and Africa RNAi Therapy Market Size and Prospect (2018-2029)
2 Company Profiles
2.1 Alnylam
2.1.1 Alnylam Details
2.1.2 Alnylam Major Business
2.1.3 Alnylam RNAi Therapy Product and Solutions
2.1.4 Alnylam RNAi Therapy Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Alnylam Recent Developments and Future Plans
2.2 Sarepta Therapeutics
2.2.1 Sarepta Therapeutics Details
2.2.2 Sarepta Therapeutics Major Business
2.2.3 Sarepta Therapeutics RNAi Therapy Product and Solutions
2.2.4 Sarepta Therapeutics RNAi Therapy Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Sarepta Therapeutics Recent Developments and Future Plans
2.3 Alnylam Pharmaceuticals
2.3.1 Alnylam Pharmaceuticals Details
2.3.2 Alnylam Pharmaceuticals Major Business
2.3.3 Alnylam Pharmaceuticals RNAi Therapy Product and Solutions
2.3.4 Alnylam Pharmaceuticals RNAi Therapy Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Alnylam Pharmaceuticals Recent Developments and Future Plans
2.4 Moderna
2.4.1 Moderna Details
2.4.2 Moderna Major Business
2.4.3 Moderna RNAi Therapy Product and Solutions
2.4.4 Moderna RNAi Therapy Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Moderna Recent Developments and Future Plans
2.5 Sanofi
2.5.1 Sanofi Details
2.5.2 Sanofi Major Business
2.5.3 Sanofi RNAi Therapy Product and Solutions
2.5.4 Sanofi RNAi Therapy Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Sanofi Recent Developments and Future Plans
2.6 Arcturus Therapeutics
2.6.1 Arcturus Therapeutics Details
2.6.2 Arcturus Therapeutics Major Business
2.6.3 Arcturus Therapeutics RNAi Therapy Product and Solutions
2.6.4 Arcturus Therapeutics RNAi Therapy Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Arcturus Therapeutics Recent Developments and Future Plans
2.7 Silence
2.7.1 Silence Details
2.7.2 Silence Major Business
2.7.3 Silence RNAi Therapy Product and Solutions
2.7.4 Silence RNAi Therapy Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Silence Recent Developments and Future Plans
2.8 Sirnaomics
2.8.1 Sirnaomics Details
2.8.2 Sirnaomics Major Business
2.8.3 Sirnaomics RNAi Therapy Product and Solutions
2.8.4 Sirnaomics RNAi Therapy Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Sirnaomics Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global RNAi Therapy Revenue and Share by Players (2018-2023)
3.2 Market Share Analysis (2022)
3.2.1 Market Share of RNAi Therapy by Company Revenue
3.2.2 Top 3 RNAi Therapy Players Market Share in 2022
3.2.3 Top 6 RNAi Therapy Players Market Share in 2022
3.3 RNAi Therapy Market: Overall Company Footprint Analysis
3.3.1 RNAi Therapy Market: Region Footprint
3.3.2 RNAi Therapy Market: Company Product Type Footprint
3.3.3 RNAi Therapy Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 Market Size Segment by Type
4.1 Global RNAi Therapy Consumption Value and Market Share by Type (2018-2023)
4.2 Global RNAi Therapy Market Forecast by Type (2024-2029)
5 Market Size Segment by Application
5.1 Global RNAi Therapy Consumption Value Market Share by Application (2018-2023)
5.2 Global RNAi Therapy Market Forecast by Application (2024-2029)
6 North America
6.1 North America RNAi Therapy Consumption Value by Type (2018-2029)
6.2 North America RNAi Therapy Consumption Value by Application (2018-2029)
6.3 North America RNAi Therapy Market Size by Country
6.3.1 North America RNAi Therapy Consumption Value by Country (2018-2029)
6.3.2 United States RNAi Therapy Market Size and Forecast (2018-2029)
6.3.3 Canada RNAi Therapy Market Size and Forecast (2018-2029)
6.3.4 Mexico RNAi Therapy Market Size and Forecast (2018-2029)
7 Europe
7.1 Europe RNAi Therapy Consumption Value by Type (2018-2029)
7.2 Europe RNAi Therapy Consumption Value by Application (2018-2029)
7.3 Europe RNAi Therapy Market Size by Country
7.3.1 Europe RNAi Therapy Consumption Value by Country (2018-2029)
7.3.2 Germany RNAi Therapy Market Size and Forecast (2018-2029)
7.3.3 France RNAi Therapy Market Size and Forecast (2018-2029)
7.3.4 United Kingdom RNAi Therapy Market Size and Forecast (2018-2029)
7.3.5 Russia RNAi Therapy Market Size and Forecast (2018-2029)
7.3.6 Italy RNAi Therapy Market Size and Forecast (2018-2029)
8 Asia-Pacific
8.1 Asia-Pacific RNAi Therapy Consumption Value by Type (2018-2029)
8.2 Asia-Pacific RNAi Therapy Consumption Value by Application (2018-2029)
8.3 Asia-Pacific RNAi Therapy Market Size by Region
8.3.1 Asia-Pacific RNAi Therapy Consumption Value by Region (2018-2029)
8.3.2 China RNAi Therapy Market Size and Forecast (2018-2029)
8.3.3 Japan RNAi Therapy Market Size and Forecast (2018-2029)
8.3.4 South Korea RNAi Therapy Market Size and Forecast (2018-2029)
8.3.5 India RNAi Therapy Market Size and Forecast (2018-2029)
8.3.6 Southeast Asia RNAi Therapy Market Size and Forecast (2018-2029)
8.3.7 Australia RNAi Therapy Market Size and Forecast (2018-2029)
9 South America
9.1 South America RNAi Therapy Consumption Value by Type (2018-2029)
9.2 South America RNAi Therapy Consumption Value by Application (2018-2029)
9.3 South America RNAi Therapy Market Size by Country
9.3.1 South America RNAi Therapy Consumption Value by Country (2018-2029)
9.3.2 Brazil RNAi Therapy Market Size and Forecast (2018-2029)
9.3.3 Argentina RNAi Therapy Market Size and Forecast (2018-2029)
10 Middle East & Africa
10.1 Middle East & Africa RNAi Therapy Consumption Value by Type (2018-2029)
10.2 Middle East & Africa RNAi Therapy Consumption Value by Application (2018-2029)
10.3 Middle East & Africa RNAi Therapy Market Size by Country
10.3.1 Middle East & Africa RNAi Therapy Consumption Value by Country (2018-2029)
10.3.2 Turkey RNAi Therapy Market Size and Forecast (2018-2029)
10.3.3 Saudi Arabia RNAi Therapy Market Size and Forecast (2018-2029)
10.3.4 UAE RNAi Therapy Market Size and Forecast (2018-2029)
11 Market Dynamics
11.1 RNAi Therapy Market Drivers
11.2 RNAi Therapy Market Restraints
11.3 RNAi Therapy Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
11.5 Influence of COVID-19 and Russia-Ukraine War
11.5.1 Influence of COVID-19
11.5.2 Influence of Russia-Ukraine War
12 Industry Chain Analysis
12.1 RNAi Therapy Industry Chain
12.2 RNAi Therapy Upstream Analysis
12.3 RNAi Therapy Midstream Analysis
12.4 RNAi Therapy Downstream Analysis
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
Published By : GlobalInfoResearch
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
